• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-05-07

  Schwartz's dissertation advances the evaluation of anti-cancer drugs in vitro by distinguishing between drug-induced growth inhibition and cell death, using both relative and fractional viability metrics. This nuanced approach improves the interpretation of compound efficacy and can guide more precise experimental design in cancer biology.

• Tacalcitol Monohydrate: Precision Modulation in Cancer and D

  2026-05-06

  Explore how Tacalcitol monohydrate, a synthetic analog of vitamin D3, redefines targeted approaches in colorectal cancer and psoriasis research. Discover distinct mechanistic insights and protocol guidance not found in standard workflows.

• Azithromycin Workflows: Applied Protocols for Bacterial Infe

  2026-05-06

  Azithromycin, a macrolide antibiotic from APExBIO, empowers researchers to dissect bacterial infection models and resistance mechanisms with high reproducibility. This article unpacks experimental workflows, troubleshooting strategies, and cross-domain applications supported by quantitative data and protocol refinements.

• Rotenone: Mitochondrial Complex I Inhibitor for Disease Mode

  2026-05-05

  Rotenone stands as the gold-standard mitochondrial Complex I inhibitor, enabling precise modeling of mitochondrial dysfunction in cellular and animal systems. Its robust induction of ROS and quantifiable impact on autophagy and apoptosis make it indispensable for neurodegenerative and metabolic research workflows.

• 3X (DYKDDDDK) Peptide: Optimizing Affinity Purification Work

  2026-05-05

  The 3X (DYKDDDDK) Peptide enables high-sensitivity detection and robust affinity purification of recombinant proteins across diverse applications. Its unique triple-epitope design improves workflow reproducibility and compatibility with metal-sensitive assays, making it an indispensable tool for advanced molecular biology and structural studies.

• 5-Methyl-CTP: Enhancing mRNA Stability for Advanced Synthesi

  2026-05-04

  5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, increases mRNA stability and translation efficiency in in vitro transcription. Its use is pivotal for mRNA synthesis with modified nucleotides, supporting both research and mRNA drug development. APExBIO supplies this nucleotide with high purity, enabling reproducible gene expression studies.

• Comparative Antibacterial Properties of Hexetidine in Mouthr

  2026-05-04

  Roberts and Addy’s 1981 study systematically compared the in vitro and in vivo antibacterial effects of four cationic antiseptics, including Hexetidine (NSC-17764), for oral use. Their work clarified Hexetidine’s activity spectrum, residual effects, and limitations, guiding subsequent experimental and clinical applications in oral infection research.

• TAK-242 (Resatorvid): Optimizing TLR4 Pathway Modulation in

  2026-05-03

  TAK-242 (Resatorvid) enables precise, nanomolar-range inhibition of TLR4 signaling, streamlining neuroinflammation and immune response assays. This guide translates the latest evidence and workflow innovations into actionable steps—delivering reproducible results for both bench and translational research.

• Atropo-Enantioselective Suzuki Coupling Yields Antimitotic B

  2026-05-02

  This study demonstrates a catalytic asymmetric Suzuki cross-coupling to synthesize an axially chiral biaryl, a structural analogue of the antimitotic alkaloid (-)-rhazinilam. The work advances the application of atropo-enantioselective catalysis for generating bioactive molecules, providing a robust approach to accessing complex chiral frameworks relevant to cytoskeletal and cancer research.

• ATRX Loss Sensitizes High-Grade Glioma to RTK and PDGFR Inhi

  2026-05-02

  Pladevall-Morera et al. (2022) identify ATRX deficiency as a key vulnerability in high-grade glioma, demonstrating heightened sensitivity of ATRX-mutant glioma cells to multi-targeted RTK and PDGFR inhibitors. These findings suggest ATRX status may inform targeted therapy selection and stratification in future clinical trials.

• AICAR Phosphate (Acadesine): Translating AMPK Activation in

  2026-05-01

  This thought-leadership article explores how AICAR phosphate (Acadesine) enables translational researchers to strategically leverage AMPK activation for targeted apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) and for modulation of inflammation. Integrating mechanistic insights with advanced protocol recommendations, the article bridges recent discoveries in AMPK-mediated cellular crosstalk with actionable experimental design, positioning APExBIO's high-purity reagent at the forefront of cancer and inflammation research.

• WAY-100635: Precision Serotonin 5-HT1A Antagonist for Behavi

  2026-04-30

  WAY-100635, a potent serotonin 5-HT1A receptor antagonist, enables high-specificity interrogation of serotonergic signaling in both in vitro and in vivo models. This article decodes experimental workflows, troubleshooting, and translational innovations rooted in recent pain and affect research, leveraging APExBIO’s rigorously validated product.

• Mitomycin C: Strategic Leverage in Translational Oncology

  2026-04-30

  This article explores the mechanistic underpinnings and translational strategies for deploying Mitomycin C as a precision antitumor antibiotic in apoptosis signaling and cancer research. By integrating evidence from in vitro and in vivo studies, we provide actionable guidance for protocol optimization and highlight how Mitomycin C, available from APExBIO, can elevate the reliability and impact of preclinical models. The discussion further contrasts established paradigms with emerging antiviral genome-editing strategies, offering a forward-looking perspective on the future of rational combination therapies.

• Optimizing Cell Assays with VX-702: Selective p38α MAPK Inhi

  2026-04-29

  This article provides a scenario-driven, evidence-backed guide for integrating VX-702 (SKU A8687) into cell viability, proliferation, and cytotoxicity assays. We address common laboratory challenges, compare supplier reliability, and highlight how VX-702's selectivity and dual-action mechanism improve reproducibility and data quality for inflammation, arthritis, and cardiovascular research.

• LGK-974: Precision PORCN Inhibitor for Wnt Pathway Research

  2026-04-29

  LGK-974, a potent and specific PORCN inhibitor from APExBIO, enables robust, reproducible inhibition of Wnt signaling in both in vitro and in vivo models—critical for dissecting Wnt-driven cancer mechanisms, including pancreatic cancer with RNF43 mutations. This guide translates cutting-edge literature and validated protocols into practical workflows, troubleshooting, and strategic insights for advanced cancer research.

406 records 16/28 page Previous Next First page 上5页 1617181920 下5页 Last page